Teva Pharmaceutical Industries Ltd.

Teva Pharmaceuticals is a global leader in generic medicines and biopharmaceuticals, headquartered in Tel Aviv, Israel. Founded in 1901, Teva has become one of the world’s largest suppliers of affordable medicines, with a diverse portfolio covering generic drugs, specialty treatments, and over-the-counter (OTC) healthcare products. The company is especially recognized for its work in neurology, respiratory diseases, and oncology, along with its strong presence in biosimilars.

Mission and Vision

Mission: To improve health and make high-quality medicines accessible to millions of people worldwide.
Vision: To be the most trusted leader in generics and biopharmaceuticals, delivering value through affordability and innovation.

Products and Services

Generic Medicines: Thousands of generics across therapeutic areas, ensuring broad access to affordable treatments.
Specialty Medicines: Notable drugs include Copaxone (for multiple sclerosis) and Austedo (for Huntington’s disease).
Biosimilars: Expanding portfolio in oncology, autoimmune, and chronic disease treatments.
OTC Products: Wide range of consumer health products distributed globally.
Research & Development: Focus on central nervous system disorders, respiratory diseases, and biologics.

Growth and Innovation
Teva grew into a global pharmaceutical powerhouse through strategic mergers and acquisitions, including Barr Pharmaceuticals and Actavis Generics. The company has expanded beyond generics into biopharmaceuticals, biosimilars, and specialty therapies. Despite challenges in recent years, including pricing pressures and legal disputes, Teva continues to strengthen its specialty pipeline and lead in biosimilar innovation.

Global Impact
Teva operates in more than 60 countries, providing medicines to over 200 million people daily. Its global presence and leadership in generics play a crucial role in healthcare systems worldwide, helping reduce costs and expand patient access. Teva’s focus on affordability, combined with innovation in biopharma, positions it as a critical player in the global healthcare industry.